These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9507842)

  • 21. Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study.
    Ozdal OL; Ozden C; Benli K; Gökkaya S; Bulut S; Memiş A
    Prostate Cancer Prostatic Dis; 2005; 8(3):215-8. PubMed ID: 15999118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
    Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV
    Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Finasteride preoperative preparation of patients with prostatic adenoma to transurethral prostatic resection].
    Tkachuk VN; Al'-Shukri SKh; Tkachuk IN
    Urologiia; 2008; (1):27, 29, 31. PubMed ID: 18652018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, placebo-controlled trial showing that finasteride reduces prostatic vascularity rapidly within 2 weeks.
    Donohue JF; Hayne D; Karnik U; Thomas DR; Foster MC
    BJU Int; 2005 Dec; 96(9):1319-22. PubMed ID: 16287453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Finasteride decreases the risk of prostatic intraepithelial neoplasia.
    Thompson IM; Lucia MS; Redman MW; Darke A; La Rosa FG; Parnes HL; Lippman SM; Coltman CA
    J Urol; 2007 Jul; 178(1):107-9; discussion 110. PubMed ID: 17499284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial.
    Etzioni RD; Howlader N; Shaw PA; Ankerst DP; Penson DF; Goodman PJ; Thompson IM
    J Urol; 2005 Sep; 174(3):877-81. PubMed ID: 16093979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
    Roehrborn CG; Bruskewitz R; Nickel JC; McConnell JD; Saltzman B; Gittelman MC; Malek GH; Gottesman JE; Suryawanshi S; Drisko J; Meehan A; Waldstreicher J;
    J Urol; 2004 Mar; 171(3):1194-8. PubMed ID: 14767299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Finasteride following balloon dilatation of the prostate. A double-blind, placebo-controlled, multicenter study.
    Lukkarinen O; Lehtonen T; Talja M; Lundstedt S; Tiitinen J; Taari K
    Ann Chir Gynaecol; 1999; 88(4):299-303. PubMed ID: 10661828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative evaluation of the effectiveness and safety of combined drug therapy of patients with benign prostatic hyperplasia with finasteride and alfuzozine].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2002; (1):19-22. PubMed ID: 11877966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of microvessel densities in rat prostate tissues treated with finasteride, bicalutamide and surgical castration: a preliminary study.
    Kaya C; Ozyurek M; Turkeri LN
    Int J Urol; 2005 Feb; 12(2):194-8. PubMed ID: 15733115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic contrast enhanced magnetic resonance imaging as a biological marker to noninvasively assess the effect of finasteride on prostatic suburethral microcirculation.
    Jia G; Heverhagen JT; Polzer H; Jacko RV; Liang J; Zhang J; Levine AL; Rosol TJ; Knopp MV
    J Urol; 2006 Nov; 176(5):2299-304. PubMed ID: 17070316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.
    Issa MM; Runken MC; Grogg AL; Shah MB
    Am J Manag Care; 2007 Feb; 13 Suppl 1():S10-6. PubMed ID: 17295600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of finasteride on the percentage of free PSA: implications in the early diagnosis of prostatic cancer].
    Morote J; Lorente JA; Raventós CX; López MA; Encabo G; De Torres I; López M; De Torres JA
    Actas Urol Esp; 1998; 22(10):835-9. PubMed ID: 9949572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume].
    Granados Loarca EA
    Arch Esp Urol; 1999 Apr; 52(3):201-8. PubMed ID: 10371735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dutasteride vs finasteride: assessment of differences in acute urinary retention rates and surgical risk outcomes in an elderly population aged > or =65 years.
    Fenter TC; Davis EA; Shah MB; Lin PJ
    Am J Manag Care; 2008 May; 14(5 Suppl 2):S154-9. PubMed ID: 18611089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: A comparative study.
    Anwarul Islam AK; Kashem MA; Shameem IA; Kibria SA
    Bangladesh Med Res Counc Bull; 2005 Aug; 31(2):54-61. PubMed ID: 16967810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of finasteride on vascular endothelial growth factor.
    Häggström S; Tørring N; Møller K; Jensen E; Lund L; Nielsen JE; Bergh A; Damber JE
    Scand J Urol Nephrol; 2002; 36(3):182-7. PubMed ID: 12201932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia].
    Botto H; Lan O; Poulain JE; Comenducci A
    Prog Urol; 2005 Dec; 15(6):1090-5. PubMed ID: 16429658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of alpha-blocker utilization in combination with 5-alpha reductase inhibitors for enlarged prostate in a managed care setting among Medicare-aged men.
    Issa MM; Lin PJ; Eaddy MT; Shah MB; Davis EA
    Am J Manag Care; 2008 May; 14(5 Suppl 2):S160-6. PubMed ID: 18611090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.